Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Assets Average (2020 - 2025)

Historic Assets Average for Revolution Medicines (RVMD) over the last 6 years, with Q3 2025 value amounting to $2.3 billion.

  • Revolution Medicines' Assets Average rose 3108.14% to $2.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year increase of 3108.14%. This contributed to the annual value of $2.3 billion for FY2024, which is 6077.22% up from last year.
  • Latest data reveals that Revolution Medicines reported Assets Average of $2.3 billion as of Q3 2025, which was up 3108.14% from $2.4 billion recorded in Q2 2025.
  • Over the past 5 years, Revolution Medicines' Assets Average peaked at $2.5 billion during Q1 2025, and registered a low of $657.8 million during Q2 2022.
  • Over the past 5 years, Revolution Medicines' median Assets Average value was $1.0 billion (recorded in 2023), while the average stood at $1.3 billion.
  • As far as peak fluctuations go, Revolution Medicines' Assets Average crashed by 1703.48% in 2022, and later surged by 11059.37% in 2024.
  • Quarter analysis of 5 years shows Revolution Medicines' Assets Average stood at $736.5 million in 2021, then rose by 11.19% to $818.9 million in 2022, then soared by 85.97% to $1.5 billion in 2023, then soared by 41.87% to $2.2 billion in 2024, then increased by 8.34% to $2.3 billion in 2025.
  • Its Assets Average was $2.3 billion in Q3 2025, compared to $2.4 billion in Q2 2025 and $2.5 billion in Q1 2025.